Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Neuro-Oncology
•
Neurology
What is the general approach to patients who are symptomatic from biopsy-negative Idiopathic hypertrophic pachymeningitis?
Related Questions
What is your strategy for treating headaches in patients with history of brain tumor?
For those rare patients now out 5 years post GBM treatment and continuous Optune, is there a point one would stop Optune?
How would you approach a patient over the age of 40 with a sub-totally resected frontal oligodendroglioma, WHO Grade II, 1p/19q co-deleted, IDH mutant, with imaging concerning for second site in the pontomedullary junction?
If memantine were started 6 weeks after completion of radiation to base of skull, would you expect any potential benefit?
Do you refer all patients with new findings of CNS or epidural disease to ED for evaluation or are there some that can be managed completely outpatient?
Is there a time interval after which you would not offer adjuvant radiotherapy for a malignant, grade 3 meningioma?
What criteria do you use to decide whether to start anticonvulsants in patients with brain metastases?
What is your approach to management of a subtotally resected pineal parenchymal tumor of intermediate differentiation (CNS WHO grade 2)?
How do you manage pregnant patients with newly identified glioblastoma?
Would you offer adjuvant radiotherapy for a gross totally resected WHO grade 2 hemangiopericytoma/MFT of the brain in a patient with active multiple sclerosis?